Core Biogenesis

Provider of UBaaS platform for recombinant protein bioproduction

placeParis, Ile De France, France calendar_todayFounded 2020 groups39 employees language corebiogenesis.com

Registered entities

Innovation

3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 106 times.

YearFilings
20221
20231
20242
20252
20261

Social engagement

Social engagement: 7.3K social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include XAnge, Entrepreneur First, Plug and Play Tech Center.

Investor typeCountShare
Venture capital563%
Private equity113%
Accelerator & incubator225%

Recent activity

17 Sep 2025
Recognition
3 Sep 2025
Event
Phacilitate #ATE25
2 Sep 2025
Event
Phacilitate #ATE25
Coming soon